cyclopentane has been researched along with amyloid beta-peptides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamura, Y; Komano, H; Oyama, F; Saido, TC; Sakaki, Y; Sato, S; Sudoh, S; Wang, R; Yanagisawa, K | 1 |
| Dzyuba, SV; Hashizume, D; Satake, M; Sato, M; Suzuki, N; Takenaka, T; Takezawa, R; Usuki, T; Yoshida, Y; Yoshimoto, Y | 1 |
2 other study(ies) available for cyclopentane and amyloid beta-peptides
| Article | Year |
|---|---|
Presenilin 1 mutations linked to familial Alzheimer's disease increase the intracellular levels of amyloid beta-protein 1-42 and its N-terminally truncated variant(s) which are generated at distinct sites.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Bacterial Agents; Brefeldin A; Cyclopentanes; Extracellular Space; Gene Expression Regulation; Genetic Linkage; Humans; Intracellular Fluid; Macrolides; Membrane Proteins; Mice; Monensin; Mutation; Peptide Fragments; Presenilin-1; Time Factors; Tumor Cells, Cultured | 1998 |
Bilobalide and PC12 cells: A structure activity relationship study.
Topics: Amyloid beta-Peptides; Animals; Cell Proliferation; Cells, Cultured; Crystallography, X-Ray; Cyclopentanes; Dose-Response Relationship, Drug; Furans; Ginkgolides; Models, Molecular; Molecular Structure; Neurons; Neuroprotective Agents; PC12 Cells; Peptide Fragments; Rats; Structure-Activity Relationship | 2020 |